56 completed, 12 unknown, 10 withdrawn, 8 terminated. 27 Phase 3, 25 Phase 4, 18 Phase 2, 17 Not applicable, 13 Phase 1.
Follow this drug Literature Review of Ferric Oxide, Saccharated trials Research Report on Ferric Oxide, Saccharated
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COMPARISON OF EFFICACY OF ORAL VS IV IRON THERAPY IN CHILDREN AGED 12-59 MONTHS, WITH IRON DEFICIENCY ANEMIA Oral ferrous sulfate, iron sucrose - Iron Deficiency Anemia in Children | Phase 2 | Not yet recruiting | Kharadar General Hospital | 100 | 2027-01-01 | 2026-06-18 |
| Comparing Two Intravenous Iron Treatments for Anemia in Kurdish Pregnant Women Intravenous Ferric Carboxymaltose (FCM), Iron Sucrose (IS) Infusion - Iron Deficiency Anemia in Pregnancy | Not applicable | Not yet recruiting | Hawler Medical University | 400 | 2026-09-01 | 2026-07-23 |
| Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer Ferric Carboxymaltose (FCM), Iron Sucrose. - Gastric Cancer (GC), Iron Deficiency Anemia (IDA) | Phase 4 | Not yet recruiting | Zhaojian Niu,MD | 160 | 2026-08-01 | 2026-08-19 |
| Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients Ferric Carboxymaltose (FCM), Iron Sucrose injection - Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease | Not applicable | Completed | Sindh Institute of Urology and Transplantation | 128 | 2025-04-01 | 2026-04-22 |
| The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion Iron sucrose, Human Erythropoietin Injection, Vitamin C, Standard Medical Care - Anemia, Iron Deficiency Anemia | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 400 | 2025-01-04 | 2026-06-02 |
| Bioequivalence Study of Iron Sucrose Injection in Healthy Participants Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 48 | 2024-11-22 | 2025-03-24 |
| Iron Administration Via Colonic TET Combined With WMT for ID Ferrous Lactate, Iron sucrose, 0.9% NaCl solution - Iron Deficiency Anemia in Childbirth | Phase 2 | Unknown | The Second Hospital of Nanjing Medical University | 60 | 2024-07-25 | 2024-07-22 |
| Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 48 | 2024-06-25 | 2024-10-08 |
| Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer IV iron - Anaemia in Ovarian Carcinoma | Phase 3 | Not yet recruiting | University of Saskatchewan | 200 | 2024-02-29 | 2024-02-08 |
| Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women Iron Carboxymaltose, Iron Sucrose Injection - Iron Deficiency Anemia (IDA), Pregnancy | Phase 4 | Completed | CMH Multan Institute of Medical Sciences | 60 | 2024-02-01 | 2025-04-06 |
| Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia Venofer 200 MG Per 10 ML Injection, Ferrous sulfate - Iron Deficiency Anemia of Pregnancy | Phase 3 | Unknown | Arrowhead Regional Medical Center | 900 | 2023-11-21 | 2024-04-16 |
| Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia Venofer 200 MG Per 10 ML Injection, Ferinject - Anemia, Iron Deficiency, Pregnancy Anemia | Phase 4 | Recruiting | Western Galilee Hospital-Nahariya | 200 | 2023-11-02 | 2026-09-11 |
| Effect of the Combined Programme on Perioperative Anaemia（CPPA） Iron Sucrose, recombinant human erythropoietin, ascorbic acid, conventional treatment - Patient Blood Management, Cardiac Surgery | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 110 | 2023-03-15 | 2025-01-10 |
| Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy Venofer - Anemia | Phase 2 | Recruiting | Fox Chase Cancer Center | 34 | 2023-03-15 | 2026-05-22 |
| Iron Therpay and Fatigue in Women of Reprodcutive Age Iron sucrose, Placebo - Fatigue Syndrome, Chronic, Fatigue | Not applicable | Completed | Central Park Medical College | 194 | 2023-02-25 | 2024-09-19 |
| Iron Supplementation for Geriatric Hip Fractures iron sucrose and ferrous lactate - Hip Fractures, Fragility Fracture | Phase 4 | Unknown | He Qifei | 444 | 2022-09-15 | 2022-09-22 |
| Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy Iron Isomaltoside 1000, ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia in Childbirth | Phase 3 | Recruiting | Saskatchewan Health Authority - Regina Area | 280 | 2022-06-06 | 2025-05-15 |
| Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy. Ferrous fumarate, MonoFer - Inflammatory Bowel Diseases | Not applicable | Unknown | Leiden University Medical Center | 152 | 2022-06-02 | 2022-10-14 |
| To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy Iron sucrose 200 mg, Iron sucrose 500 mg - Pregnancy | Not applicable | Withdrawn | HaEmek Medical Center, Israel | 2022-01-01 | 2022-11-08 | |
| Iron Sucrose in Patients With Iron Deficiency and POTS Sucrose, Placebo, Tilt Table Test - Iron-deficiency, Postural Orthostatic Tachycardia Syndrome | Phase 2 | Withdrawn | Mayo Clinic | 2021-04-01 | 2023-06-13 |
Showing 20 of 99. Sign in to see all of them.
Anemia (38) · Anemia, Iron-Deficiency (33) · Iron Deficiencies (13) · Renal Insufficiency, Chronic (12) · Kidney Failure, Chronic (4) · Altitude Sickness (3) · Inflammatory Bowel Diseases (3) · Renal Insufficiency (3) · Colitis, Ulcerative (2) · Crohn Disease (2) · Hip Fractures (2) · Hypertension, Pulmonary (2) · Hypoxia (2) · Inflammation (2) · Kidney Diseases (2)
American Regent, Inc. (11) · AMAG Pharmaceuticals, Inc. (5) · Pharmacosmos A/S (4) · Denver Health and Hospital Authority (3) · University of Oxford (3) · Assiut University (2) · Azad Pharma AG (2) · HaEmek Medical Center, Israel (2) · Hospital Clinic of Barcelona (2) · Mayo Clinic (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Sichuan Huiyu Pharmaceutical Co., Ltd (2) · Watson Pharmaceuticals (2) · Anemia Working Group Romania (1) · Arrowhead Regional Medical Center (1)
United States (31) · China (9) · Canada (8) · United Kingdom (8) · Poland (5) · Spain (5) · Pakistan (4) · Austria (3) · Germany (3) · Israel (3) · Lithuania (3) · Thailand (3) · Australia (2) · Belgium (2) · Hungary (2)
Mark A Falone, MD (4) · Fredric M Pieracci, MD, MPH (3) · Adel R. Rizkala, Pharm.D., MS (1) · Amie Jones, MD (1) · Andreea Ciudin (1) · Andrew Artz, MD (1) · Bernard DePrijck, MD (1) · Bradley Lash, MD (1) · Bret Taback, MD (1) · Carol Duffy, D.O.,FACC (1) · Christoph Gasche, Professor (1) · Chun Wan (1)
PMID 15824508, PMID 16316362, PMID 17622274, PMID 18191732, PMID 19406557, PMID 19809026, PMID 20466657, PMID 20876669, PMID 22940889, PMID 23514036, PMID 23963731, PMID 24099839, PMID 24458078, PMID 24797376, PMID 26848182, PMID 26971581, PMID 28372549, PMID 30121943, PMID 30802204, PMID 31243803, PMID 31413088, PMID 31811820, PMID 32049331, PMID 32053933, PMID 34171389, PMID 34839481, PMID 35113024, PMID 36107229, PMID 37096093, PMID 42261111
2009 (1), 2016 (1), U01AG034661 (1), U01DK071633 (1)